Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00037661 | Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye | PHASE3 | COMPLETED | 222 | — | — | Apr 1, 2002 | Mar 1, 2003 | Oct 2, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| INS365 Ophthalmic Solution | DRUG | - |
Inclusion Criteria: * have Non-Sjogren's associated dry eye disease with symptoms lasting greater than 6 months * had intermittent or regular artificial tear use within past 3 months Exclusion Criteria: * had LASIK surgery * had punctal occlusion or cauterization within last 3 months